(Q386119)

DrugBank

image of molecular model or crystal lattice model

17 November 2015

Natalizumab 4IRZ.png
2,048 × 2,048; 155 KB

depicts

space-filling model

0 references

defined daily dose

10 milligram

route of administration

parenteral route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=L04AA23

active ingredient in

Natalizumab Elan Pharma

1 reference

European Medicines Agency product number

EMEA/H/C/000624

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000624/human_med_000919.jsp

European Medicines Agency product number

22 March 2017

Tysabri

1 reference

EMEA/H/C/000603

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000603/human_med_001119.jsp

World Health Organisation international non-proprietary name

22 March 2017

natalizumab (English)

1 reference

lower respiratory tract infection

Natalizumab (English)

19 January 2016

0 references

0 references

0 references

urinary tract infection

0 references

0 references

0 references

0 references

0 references

0 references

medical condition treated

secondary progressive multiple sclerosis

1 reference

Drug Indications Extracted from FAERS

relapsing-remitting multiple sclerosis

2 October 2018

1 reference

Drug Indications Extracted from FAERS

2 October 2018

multiple sclerosis

1 reference

Drug Indications Extracted from FAERS

intravenous infusion and defusion

2 October 2018

Crohn's disease

0 references

route of administration

0 references

legal status (medicine)

medical prescription

location

United States of America

August 2023

0 references

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category C

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

1 reference

Natalizumab (English)

DrugBank

17 November 2015

1 reference

Medical Subject Headings

15 March 2018

1 reference

Natalizumab (English)

publication date

17 November 2015

Identifiers

1 reference

Natalizumab (English)

17 November 2015

1 reference

Hazardous Substances Data Bank

Natalizumab (English)

19 January 2016

1 reference

28 October 2019

Natalizumab (English)

10 May 2021

0 references

1 reference

Guide to Pharmacology Ligand ID

Natalizumab (English)

publication date

17 November 2015

0 references

Natalizumab

0 references

MeSH tree code

D12.776.124.486.485.114.224.060.813

0 references

D12.776.124.790.651.114.224.060.813

0 references

D12.776.377.715.548.114.224.200.813

0 references

1 reference

26 February 2018

0 references

1 reference

NATALIZUMAB (English)

MedlinePlus drug identifier

19 January 2016

a605006

0 references

PatientsLikeMe treatment ID

0 references

1 reference

NATALIZUMAB (English)